Benzenesulfonamide‐Imidazole Hybrids as Human Carbonic Anhydrase Inhibitors
Archiv der Pharmazie · 2026
DOI: 10.1002/ardp.70369 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archiv der Pharmazie, 2026. Verfasst von Jovita Marcinkevičiūtė und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biothermodynamics and Drug Design, Institute of Biotechnology, Life Sciences Center, Vilnius University, Vilnius, Lithuania. Hauptthemen laut MEDLINE: Sulfonamides, Carbonic Anhydrase Inhibitors, Imidazoles, Carbonic Anhydrases. Die Arbeit nennt 31 Literaturangaben.
Abstract (Originalsprache)
The high structural similarity among the catalytically active human carbonic anhydrase (CA) isozymes makes the identification of high‐affinity, isozyme‐selective ligands particularly challenging. This study investigates benzenesulfonamide–imidazole hybrids as inhibitors of CAs and explores structural features of their interactions. Binding affinity was quantified by thermal shift assay, while isothermal titration calorimetry and enzymatic inhibition assays were used to further characterize ligand–CA interactions. Most of the synthesized imidazole‐bearing compounds showed high nanomolar affinity for CAII, CAVII, and CAIX isozymes, and their interactions were enthalpically favorable. Crystal structures of CA isozyme–ligand complexes indicate that hydrophobic interactions are the dominant factor in the binding of the examined benzenesulfonamide ligands ( 4a , 4b , 8 , and 12 ) with CAI, CAII, CAXII, and CAXIII. Combined studies of protein–ligand binding and inhibition, and X‐ray crystallography enable analysis of the structural factors responsible for high affinity, which is essential for developing more potent and selective inhibitors for a particular CA isozyme.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biothermodynamics and Drug Design, Institute of Biotechnology, Life Sciences Center, Vilnius University, Vilnius, Lithuania.
- Department of Organic Chemistry, Kaunas University of Technology, Kaunas, Lithuania.
- Department of Protein-DNA Interactions, Institute of Biotechnology, Life Sciences Center, Vilnius University, Vilnius, Lithuania.
ORCID-Profile: Martynas Bagdonas, Valdas Vainauskas, Elena Manakova, Marius Gedgaudas, Daumantas Matulis, Asta Zubrienė
Zitieren
APA
Marcinkevičiūtė, J., Bagdonas, M., Vainauskas, V., Smirnov, A., Manakova, E., Mickevičiūtė, A., Juozapaitienė, V., Gedgaudas, M., Mickevičius, V., Matulis, D., & Zubrienė, A. (2026). Benzenesulfonamide‐Imidazole Hybrids as Human Carbonic Anhydrase Inhibitors. Archiv der Pharmazie. https://doi.org/10.1002/ardp.70369
Vancouver
Marcinkevičiūtė J, Bagdonas M, Vainauskas V, Smirnov A, Manakova E, Mickevičiūtė A, et al. Benzenesulfonamide‐Imidazole Hybrids as Human Carbonic Anhydrase Inhibitors. Archiv der Pharmazie. 2026. doi:10.1002/ardp.70369
BibTeX
@article{Marcinkeviit2026,
author = {Marcinkevičiūtė, Jovita and Bagdonas, Martynas and Vainauskas, Valdas and Smirnov, Alexey and Manakova, Elena and Mickevičiūtė, Aurelija and Juozapaitienė, Vaida and Gedgaudas, Marius and Mickevičius, Vytautas and Matulis, Daumantas and Zubrienė, Asta},
title = {Benzenesulfonamide‐Imidazole Hybrids as Human Carbonic Anhydrase Inhibitors},
journal = {Archiv der Pharmazie},
year = {2026},
doi = {10.1002/ardp.70369}
}
EUVIMED